Procter & Gamble’s (PG) “Outperform” Rating Reiterated at Royal Bank Of Canada

Procter & Gamble (NYSE:PG)‘s stock had its “outperform” rating reissued by Royal Bank Of Canada in a research note issued on Tuesday, Benzinga reports. They presently have a $166.00 target price on the stock. Royal Bank Of Canada’s price target indicates a potential upside of 5.34% from the stock’s previous close.

Other analysts also recently issued research reports about the stock. Bank of America lowered their price objective on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating for the company in a research report on Friday, July 10th. Citigroup boosted their target price on shares of Procter & Gamble from $170.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research note on Monday, September 21st. Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Friday, August 7th. Finally, Sanford C. Bernstein reaffirmed a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a report on Monday, August 24th. Fourteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has a consensus rating of “Moderate Buy” and a consensus target price of $162.20.

Procter & Gamble Price Performance

PG stock opened at $157.59 on Tuesday. The firm has a market cap of $366.02 billion, a P/E ratio of 23.80, a price-to-earnings-growth ratio of 3.96 and a beta of 0.39. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. Procter & Gamble has a 1 year low of $137.62 and a 1 year high of $167.25. The stock has a 50-day simple moving average of $147.11 and a 200-day simple moving average of $146.62.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, topping the consensus estimate of $1.41 by $0.02. The firm had revenue of $21.20 billion for the quarter, compared to analyst estimates of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. Procter & Gamble’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts predict that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Paul Gama sold 2,225 shares of the company’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $323,381.50. Following the sale, the chief executive officer owned 51,124 shares in the company, valued at approximately $7,430,362.16. This represents a 4.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Marc S. Pritchard sold 4,030 shares of the company’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $579,473.70. Following the completion of the sale, the insider owned 187,001 shares in the company, valued at approximately $26,888,873.79. This trade represents a 2.11% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 15,135 shares of company stock worth $2,189,970 over the last ninety days. Insiders own 0.23% of the company’s stock.

Institutional Trading of Procter & Gamble

Hedge funds and other institutional investors have recently bought and sold shares of the company. Net Worth Advisory Group boosted its position in Procter & Gamble by 13.2% during the third quarter. Net Worth Advisory Group now owns 6,019 shares of the company’s stock worth $866,000 after purchasing an additional 702 shares during the period. Boyd Wealth Management LLC raised its position in shares of Procter & Gamble by 12.7% in the third quarter. Boyd Wealth Management LLC now owns 4,146 shares of the company’s stock valued at $602,000 after purchasing an additional 468 shares during the period. Lakeside Advisors INC. lifted its stake in shares of Procter & Gamble by 2.4% during the 3rd quarter. Lakeside Advisors INC. now owns 38,587 shares of the company’s stock worth $5,606,000 after buying an additional 905 shares during the last quarter. Focused Alpha LLC bought a new stake in shares of Procter & Gamble during the 3rd quarter worth about $224,000. Finally, Sumitomo Mitsui DS Asset Management Company Ltd boosted its holdings in shares of Procter & Gamble by 1.4% during the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 593,845 shares of the company’s stock worth $86,274,000 after buying an additional 8,378 shares during the period. 65.77% of the stock is owned by institutional investors.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Dividend reliability remains a major attraction. Procter & Gamble is highlighted as a “Dividend King” with roughly seven decades of consecutive payout increases. Its income consistency and relatively low-beta business model may appeal to investors seeking stability amid interest-rate and market volatility. Rising Income Over Big Yields: 4 Dividend Kings That Have Raised Payouts for 70 Years Straight
• Positive Sentiment: Innovation efforts could revive organic sales growth. New products, AI-enabled capabilities, productivity initiatives and efforts to strengthen brand market share are being viewed as potential longer-term catalysts. Procter & Gamble’s Innovation Push: Catalyst for Long-Term Growth?
• Positive Sentiment: Head & Shoulders is receiving a targeted product refresh. The new Scalp Care Collection uses clinically tested formulas aimed at dryness, oiliness and sensitivity, potentially improving brand relevance and supporting premium, science-led growth. Why Is Procter & Gamble Refreshing Its Scalp Care Playbook Now?
• Neutral Sentiment: Fiscal first-quarter results are the immediate catalyst. Analysts expect PG to report before the market opens on October 22, with attention on organic sales, volumes, pricing, margins and management’s outlook. The company’s prior quarter showed modest revenue growth and an EPS beat, but revenue fell short of estimates. Procter & Gamble Reports Q1 Earnings on October 22
• Negative Sentiment: Pricing remains a key risk. The earnings preview frames the central tension as a possible recovery in sales volumes versus pricing headwinds. If consumers resist higher prices or volumes remain weak, revenue and organic-growth expectations could come under pressure. Procter & Gamble Earnings Preview: Volume Recovery vs. Pricing Headwind

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.